ArticleRadiology case reports2026
Obstructive hydrocephalus secondary to an anterior mesencephalic cavernous malformation with familial cerebral cavernous malformation syndrome: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral Cavernous malformations (CCM) are the second most common vascular malformation of the central nervous system accounting (CNS) for 5%-10% of vascular malformations in the CNS with a prevalence of 0.5%. Most CCM are supratentorial with fewer than 20% located in the brainstem, mostly in the pons but very rarely in the anterior mesencephalon. The optimal treatment strategy for anterior mesencephalic cerebral cavernous malformations (AMCCM) is still debatable. Up to 20% of CCM are familial with patients presenting with multiple CCM. We report the case of a 62 year-old female who presented with diplopia, gait disturbance and poor speech. No clinical improvement was noted after an initial treatment with steroids for a supposedly unidentified neuroinflammatory disease. When she later presented with impaired consciousness, aphasia, right abducens nerve palsy and left hemiparesia, an urgent brain MRI with gradient echo sequence revealed an obstructive hydrocephalus secondary to an anterior mesencephalic cerebral cavernous malformation with subacute hemorrhage (Zabramski type I) along with numerous CCM typical of familial cerebral cavernous malformation (FCCM) syndrome. The urgent insertion of a ventriculoperitoneal (VP) shunt allowed progressive recovery of a normal consciousness as well as a normal motor function in all 4 limbs, which enabled her to regain autonomous ambulation albeit with a broad-based gait. No CCM re-hemorrhage occurred after 9 months of follow-up. Obstructive hydrocephalus secondary to anterior mesencephalic cerebral cavernous malformations was treated with VP shunt without re-hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.